1370 related articles for article (PubMed ID: 25887269)
41. Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling.
Sun XJ; Li XQ; Wang XL; Tan WF; Wang JK
PLoS One; 2015; 10(4):e0122752. PubMed ID: 25875290
[TBL] [Abstract][Full Text] [Related]
42. The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state.
Jiang W; Luo F; Lu Q; Liu J; Li P; Wang X; Fu Y; Hao K; Yan T; Ding X
Chem Biol Interact; 2016 Jan; 243():127-34. PubMed ID: 26363199
[TBL] [Abstract][Full Text] [Related]
43. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
Wang C; Li Q; Li T
Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
[No Abstract] [Full Text] [Related]
44. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
45. Essential oil from Cinnamomum cassia Presl bark regulates macrophage polarization and ameliorates lipopolysaccharide-induced acute lung injury through TLR4/MyD88/NF-κB pathway.
Liu F; Yang Y; Dong H; Zhu Y; Feng W; Wu H
Phytomedicine; 2024 Jul; 129():155651. PubMed ID: 38688144
[TBL] [Abstract][Full Text] [Related]
46. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Shen Y; Sun Z; Guo X
Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
[TBL] [Abstract][Full Text] [Related]
47. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
48. Apocynin ameliorates endotoxin-induced acute lung injury in rats.
Abdelmageed ME; El-Awady MS; Suddek GM
Int Immunopharmacol; 2016 Jan; 30():163-170. PubMed ID: 26687059
[TBL] [Abstract][Full Text] [Related]
49. Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo.
Zhao L; Zhang Z; Li P; Gao Y; Shi Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3301-3312. PubMed ID: 37930390
[TBL] [Abstract][Full Text] [Related]
50. Effects of Zinc Finger Protein A20 on Lipopolysaccharide (LPS)-Induced Pulmonary Inflammation/Anti-Inflammatory Mediators in an Acute Lung Injury/Acute Respiratory Distress Syndrome Rat Model.
Wu DQ; Wu HB; Zhang M; Wang JA
Med Sci Monit; 2017 Jul; 23():3536-3545. PubMed ID: 28724884
[TBL] [Abstract][Full Text] [Related]
51. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
[TBL] [Abstract][Full Text] [Related]
53. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
Wu X; Lin L; Wu H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
55. Sesamin Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibition of TLR4 Signaling Pathways.
Qiang L; Yuan J; Shouyin J; Yulin L; Libing J; Jian-An W
Inflammation; 2016 Feb; 39(1):467-472. PubMed ID: 26468152
[TBL] [Abstract][Full Text] [Related]
56. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
Li G; Li J; Zhou Q; Song X; Liang H; Huang L
Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
[TBL] [Abstract][Full Text] [Related]
57. Esculin Inhibits the Inflammation of LPS-Induced Acute Lung Injury in Mice Via Regulation of TLR/NF-κB Pathways.
Tianzhu Z; Shumin W
Inflammation; 2015 Aug; 38(4):1529-36. PubMed ID: 25676436
[TBL] [Abstract][Full Text] [Related]
58. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
60. YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway.
Xia Y; S D; Jiang S; Fan R; Wang Y; Wang Y; Tang J; Zhang Y; He RL; Yu B; Kou J
Biomed Pharmacother; 2018 Dec; 108():906-913. PubMed ID: 30372902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
